Indrayani Biotech received an Income Tax Assessment Order dated March 26, 2025, raising a demand of ₹13.90 Crores.
The company has filed an appeal before the Income Tax Appellate Tribunal (ITAT) contesting the demand.
Management, based on legal advice, expects no material adverse financial impact from this demand.
The disclosure is made pursuant to SEBI Listing Regulations and Circular SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123.